Intermede Investment Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-226,803	Closed	-$171M	–	30
2021 Q4	$171M	Buy	226,803 +6,625	+3%	+$4.96M	3.53%	13
2021 Q3	$164M	Buy	220,178 +33,204	+18%	+$24.9M	3.78%	12
2021 Q2	$120M	Buy	186,974 +50,600	+37%	+$30.8M	2.74%	21
2021 Q1	$77.9M	Sell	136,374 -88,439	-39%	-$52.4M	1.99%	24
2020 Q4	$131M	Buy	224,813 +43,641	+24%	+$24.9M	3.79%	16
2020 Q3	$93.4M	Buy	181,172 +4,691	+3%	+$2.38M	3.9%	13
2020 Q2	$79.7M	Sell	176,481 -40,057	-18%	-$17.7M	3.9%	17
2020 Q1	$75.9M	Sell	216,538 -3,663	-2%	-$1.35M	4.47%	13
2019 Q4	$81.5M	Buy	220,201 +25,391	+13%	+$8.95M	4.12%	17
2019 Q3	$64.8M	Buy	194,810 +53,569	+38%	+$17.5M	3.6%	17
2019 Q2	$44.2M	Buy	141,241 +25,066	+22%	+$7.51M	2.61%	21
2019 Q1	$35.5M	Buy	116,175 +34,779	+43%	+$9.39M	2.21%	22
2018 Q4	$18.9M	Buy	+81,396	New	+$21.8M	1.51%	26